Ascorbic acid for the common cold. A prophylactic and therapeutic trial

T. R. Karlowski, T. C. Chalmers, L. D. Frenkel, A. Z. Kapikian, T. L. Lewis and J. M. Lynch

Three hundred eleven employees of the National Institutes of Health volunteered to take 1 gm of ascorbic acid or lactose placebo in capsules three times a day for nine months. At the onset of a cold, the volunteers were given an additional 3 gm daily of either a placebo or ascorbic acid. One hundred ninety volunteers completed the study. Dropouts were defined as those who missed at least one month of drug ingestion. They represented 44% of the placebo group and 34% of those taking ascorbic acid. Analysis of these data showed that ascorbic acid had at best only a minor influence on the duration and severity of colds, and that the effects demonstrated might be explained equally well by a break in the double blind.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

RE: LETTER TO THE EDITOR ON "BIAS IN CLINICAL INTERVENTION RESEARCH"
Marmor et al.
Am J Epidemiol 2008;167:500-501.
FULL TEXT  

THE AUTHOR REPLIES
Hemila
Am J Epidemiol 2008;167:501-502.
FULL TEXT  

RE: "BIAS IN CLINICAL INTERVENTION RESEARCH"
Hemila
Am J Epidemiol 2007;165:1219-1219.
FULL TEXT  

THE AUTHOR REPLIES
Gluud
Am J Epidemiol 2007;165:1219-1220.
FULL TEXT  

Bias in Clinical Intervention Research
Gluud
Am J Epidemiol 2006;163:493-501.
ABSTRACT | FULL TEXT  

Is Acupuncture Analgesia an Expectancy Effect?: Preliminary Evidence Based on Participants' Perceived Assignments in Two Placebo-Controlled Trials
Bausell et al.
Eval Health Prof 2005;28:9-26.
ABSTRACT  

Double blind, you have been voted off the island!
Devereaux et al.
Evid. Based Ment. Health 2002;5:36-37.
FULL TEXT  

"Double blind, you are the weakest link -- goodbye!"
Devereaux et al.
Evid. Based Nurs. 2002;5:36-37.
FULL TEXT  

""Double blind, you are the weakest link -- goodbye!""
Devereaux et al.
Evid. Based Med. 2002;7:4-5.
FULL TEXT  

Physician Interpretations and Textbook Definitions of Blinding Terminology in Randomized Controlled Trials
Devereaux et al.
JAMA 2001;285:2000-2003.
ABSTRACT | FULL TEXT  

Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology
Schulz et al.
BMJ 1996;312:742-744.
ABSTRACT | FULL TEXT